Timothy Barabe - Veeva Systems Independent Director
| VEEV Stock | USD 199.54 0.34 0.17% |
Director
Mr. Timothy C. Barabe is Independent Director of Veeva Systems Inc. Mr. Barabe has served as a member of our Board since September 2015. He retired in 2013 as Executive Vice President and Chief Financial Officer of Affymetrix, Inc. Previously, from July 2006 until March 2010, he was Senior Vice President and Chief Financial Officer of Human Genome Sciences, Inc. Mr. Barabe served as Chief Financial Officer of Regent Medical Limited, a U.K.based, privately owned, surgical supply company, from 2004 to 2006. He was with Novartis AG from 1982 through August 2004, where he served in a succession of senior executive positions in finance and general management, most recently as the Chief Financial Officer of Sandoz GmbH, the generic pharmaceutical subsidiary of Novartis. Mr. Barabe serves on the board of directors of ArQule, Inc. and Selecta Biosciences, Inc. and served on the board of directors of Opexa Therapeutics from March 2014 to September 2017. Mr. Barabe also serves on the board of directors of Vigilant Biosciences, a private medical device company, and Project Open Hand, a nonprofit organization. He received his Bachelor of Business Administration degree in Finance from the University of Massachusetts and his MBA from the University of Chicago since 2015.
| Age | 67 |
| Tenure | 9 years |
| Address | 4280 Hacienda Drive, Pleasanton, CA, United States, 94588 |
| Phone | 925 452 6500 |
| Web | https://www.veeva.com |
Veeva Systems Management Efficiency
The company has return on total asset (ROA) of 0.0501 % which means that it generated a profit of $0.0501 on every $100 spent on assets. This is way below average. Similarly, it shows a return on stockholder's equity (ROE) of 0.1258 %, meaning that it created $0.1258 on every $100 dollars invested by stockholders. Veeva Systems' management efficiency ratios could be used to measure how well Veeva Systems manages its routine affairs as well as how well it operates its assets and liabilities. At this time, Veeva Systems' Return On Assets are fairly stable compared to the past year. Return On Equity is likely to climb to 0.20 in 2024, whereas Return On Tangible Assets are likely to drop 0.1 in 2024. At this time, Veeva Systems' Asset Turnover is fairly stable compared to the past year.Similar Executives
| Showing other executives | DIRECTOR Age | ||
| Neal Moszkowski | R1 RCM Inc | 52 | |
| Debra McCowan | HealthEquity | 46 | |
| Nikhil Rao | 10X Genomics | N/A | |
| Charles Ditkoff | R1 RCM Inc | 55 | |
| James Bryant | 10X Genomics | N/A | |
| Ian Sacks | R1 RCM Inc | 47 | |
| Bert Zimmerli | R1 RCM Inc | 65 | |
| Ian Sacks | HealthEquity | 47 | |
| Michael Leavitt | HealthEquity | 66 | |
| Michael Feiner | R1 RCM Inc | 75 | |
| Manu Rana | HealthEquity | 45 | |
| Alex Mandl | R1 RCM Inc | 74 | |
| Evelyn Dilsaver | HealthEquity | 62 | |
| Gayle Wellborn | HealthEquity | 56 | |
| Frank Corvino | HealthEquity | 68 | |
| Jill Smith | R1 RCM Inc | 59 | |
| Frank Medici | HealthEquity | 53 | |
| Albert Zimmerli | R1 RCM Inc | 66 | |
| Joseph Impicciche | R1 RCM Inc | 60 | |
| Anthony Speranzo | R1 RCM Inc | 69 | |
| Adrian Dillon | HealthEquity | 63 | |
Management Performance
| Return On Equity | 0.13 | ||||
| Return On Asset | 0.0501 |
Veeva Systems Class Leadership Team
Elected by the shareholders, the Veeva Systems' board of directors comprises two types of representatives: Veeva Systems inside directors who are chosen from within the company, and outside directors, selected externally and held independent of Veeva. The board's role is to monitor Veeva Systems' management team and ensure that shareholders' interests are well served. Veeva Systems' inside directors are responsible for reviewing and approving budgets prepared by upper management to implement core corporate initiatives and projects. On the other hand, Veeva Systems' outside directors are responsible for providing unbiased perspectives on the board's policies.
| Ato Garrett, Director Relations | ||
| Paul Sekhri, Independent Director | ||
| Nitsa Zuppas, Chief Marketing Officer | ||
| Matthew Wallach, Co-Founder and Pres | ||
| Timothy Barabe, Independent Director | ||
| Josh Faddis, Vice President General Counsel, Corporate Secretary | ||
| Alan Mateo, Executive Vice President of Global Sales | ||
| Pinal Patel, Chief Officer | ||
| Eleni Zuppas, Chief Officer | ||
| Kristine Diamond, Principal Officer | ||
| Jonathan Faddis, Senior Vice President, General Counsel, Corporate Secretary | ||
| Jacques Mourrain, Vice Compliance | ||
| Timothy Cabral, Director | ||
| Ronald Codd, Independent Director | ||
| Peter Gassner, Chief Executive Officer, Director | ||
| Michele OConnor, Principal Accounting Officer | ||
| Frederic Lequient, Senior Vice President - Global Customer Services | ||
| Tina Hunt, Director | ||
| Paul Chamberlain, Independent Director | ||
| Mark Carges, Independent Director | ||
| Rick Lund, Investor Relations Director | ||
| Gordon Ritter, Independent Chairman of the Board | ||
| Priscilla Hung, Director | ||
| Gunnar Hansen, Director Relations | ||
| Mary Hedley, Independent Director | ||
| E Zuppas, Chief Marketing Officer | ||
| Brent Bowman, Chief Financial Officer | ||
| Thomas Schwenger, President, Chief Operating Officer | ||
| Marshall Mohr, Director |
Veeva Stock Performance Indicators
The ability to make a profit is the ultimate goal of any investor. But to identify the right stock is not an easy task. Is Veeva Systems a good investment? Although profit is still the single most important financial element of any organization, multiple performance indicators can help investors identify the equity that they will appreciate over time.
| Return On Equity | 0.13 | ||||
| Return On Asset | 0.0501 | ||||
| Profit Margin | 0.22 % | ||||
| Operating Margin | 0.21 % | ||||
| Current Valuation | 28.22 B | ||||
| Shares Outstanding | 161.32 M | ||||
| Shares Owned By Insiders | 8.19 % | ||||
| Shares Owned By Institutions | 84.18 % | ||||
| Number Of Shares Shorted | 2.39 M | ||||
| Price To Earning | 78.67 X |
Also Currently Popular
Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.When determining whether Veeva Systems Class is a strong investment it is important to analyze Veeva Systems' competitive position within its industry, examining market share, product or service uniqueness, and competitive advantages. Beyond financials and market position, potential investors should also consider broader economic conditions, industry trends, and any regulatory or geopolitical factors that may impact Veeva Systems' future performance. For an informed investment choice regarding Veeva Stock, refer to the following important reports:Check out World Market Map to better understand how to build diversified portfolios, which includes a position in Veeva Systems Class. Also, note that the market value of any company could be tightly coupled with the direction of predictive economic indicators such as signals in income. Note that the Veeva Systems Class information on this page should be used as a complementary analysis to other Veeva Systems' statistical models used to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Cryptocurrency Center module to build and monitor diversified portfolio of extremely risky digital assets and cryptocurrency.
Complementary Tools for Veeva Stock analysis
When running Veeva Systems' price analysis, check to measure Veeva Systems' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Veeva Systems is operating at the current time. Most of Veeva Systems' value examination focuses on studying past and present price action to predict the probability of Veeva Systems' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Veeva Systems' price. Additionally, you may evaluate how the addition of Veeva Systems to your portfolios can decrease your overall portfolio volatility.
| Sign In To Macroaxis Sign in to explore Macroaxis' wealth optimization platform and fintech modules | |
| Volatility Analysis Get historical volatility and risk analysis based on latest market data | |
| Price Transformation Use Price Transformation models to analyze the depth of different equity instruments across global markets | |
| Portfolio Comparator Compare the composition, asset allocations and performance of any two portfolios in your account | |
| Content Syndication Quickly integrate customizable finance content to your own investment portal | |
| Correlation Analysis Reduce portfolio risk simply by holding instruments which are not perfectly correlated | |
| Options Analysis Analyze and evaluate options and option chains as a potential hedge for your portfolios | |
| FinTech Suite Use AI to screen and filter profitable investment opportunities |
Is Veeva Systems' industry expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Veeva Systems. If investors know Veeva will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Veeva Systems listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Quarterly Earnings Growth (0.23) | Earnings Share 3.21 | Revenue Per Share 14.724 | Quarterly Revenue Growth 0.119 | Return On Assets 0.0501 |
The market value of Veeva Systems Class is measured differently than its book value, which is the value of Veeva that is recorded on the company's balance sheet. Investors also form their own opinion of Veeva Systems' value that differs from its market value or its book value, called intrinsic value, which is Veeva Systems' true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Veeva Systems' market value can be influenced by many factors that don't directly affect Veeva Systems' underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Veeva Systems' value and its price as these two are different measures arrived at by different means. Investors typically determine if Veeva Systems is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Veeva Systems' price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.